Pcn120 Cost-utility of Docetaxel Compared With Best Supportive Care and Pemetrexed in Second Line Treatment of Non-small Cell Lung Cancer in Poland
Year: 2009
Type: conference-abstract
Source: Value in Health
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W1977053584
